← Back to Search

Community Mobilization for High Blood Pressure

N/A

Waitlist Available

Led By Olugbenga Ogedegbe, MD

Research Sponsored by NYU Langone Health

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Be older than 18 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up month 24

Awards & highlights

No Placebo-Only Group

Summary

This trial will use the EPIS model in a type-2 hybrid design to explore barriers and facilitators of Clean Fuel-Clean-Stove (CF-CS) use, develop a culturally-tailored CM strategy for CF-CS use, and compare the effect of CM vs. a self-directed condition (i.e. receipt of information on CF-CS use without CM) on adoption of CF-CS use and systolic BP reduction in a cluster RCT of 640 households across 32 peri-urban communities in Nigeria.

Who is the study for?

This trial is for families in peri-urban Nigerian communities who primarily use kerosene, charcoal, or firewood for cooking. The primary cook must be a female without a paid housemaid, and the household should have 2 to 7 members. The key decision-maker at home must agree to participate and not plan to move within the next year.

What is being tested?

The study tests if community mobilization (CM) can increase clean cookstove usage and reduce hypertension compared to just giving information without CM support. It's conducted in three phases: exploring barriers, implementing CM in a randomized trial of 640 households across 32 communities, then checking long-term sustainability.

What are the potential side effects?

Since this intervention involves social strategies rather than medical treatments, there are no direct side effects like you'd expect with drugs. However, changes in cooking practices could indirectly affect lifestyle or health.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ month 24

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~month 24

This trial's timeline: 3 weeks for screening, Varies for treatment, and month 24 for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.

Primary study objectives

Percent of Participants who have Adopted CF-CS at Baseline

Percent of Participants who have Adopted CF-CS at Month 12

Secondary study objectives

Change in Mean Systolic Blood Pressure from Baseline to Month 12

Percent of Participants who Have Adopted CF-CS at Month 24

Awards & Highlights

No Placebo-Only Group

All patients enrolled in this study will receive some form of active treatment.

Trial Design

2Treatment groups

Experimental Treatment

Active Control

Group I: CM Intervention GroupExperimental Treatment1 Intervention

Cluster. RCT of 16 urban and rural communities. Community mobilizers and health education officers will facilitate use of CF-CS (bioethanol and LPG fuels/stoves) and educate households on HAP exposure throughout the intervention period

Group II: Self-Directed GroupActive Control1 Intervention

Receive information on CFCS use and education on HAP in 16 urban and rural communities; will not receive the CM intervention

Treatment

First Studied

Drug Approval Stage

How many patients have taken this drug

Community Mobilization

2011

N/A

~71890

Do I qualify?Apply below to find out